Kezar Life Sciences Inc (KZR) Stock Forecast & Price Target
Kezar Life Sciences Inc · NASDAQ
$0.13-0.00 (-1.96%)
15-min delayed · Jul 28, 8:00 AM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Kezar Life Sciences Inc, 0 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets span $5.00 to $7.00, a moderate spread. The average target of $6.00 sits 4700% above the current $0.13. The rating mix has held broadly steady over recent months.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Hold
Strong Buy00%
Buy00%
Hold3100%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Kezar Life Sciences Inc.
As of Jul, 0 of 3 firms rate KZR a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
Top analysts covering Kezar Life Sciences Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on KZR.
#1
Raghuram Selvaraju
HC Wainwright & Co. · Rank #249
Hold
No targeton KZR
Overall win rate
37%
+ Follow
#2
Derek Archila
Wells Fargo · Rank #350
Hold
$5.00+3900.0% to target
Overall win rate
32%
+ Follow
#3
MR
Maury Raycroft
Jefferies
Hold
$7.00+5500.0% to target
Coverage
—
+ Follow
#4
MP
Matt Phipps
William Blair
Hold
No targeton KZR
Coverage
—
+ Follow
#5
Phil Nadeau
TD Cowen
Buy
No targeton KZR
Coverage
—
+ Follow
KZR stock forecast FAQ
What is KZR's average 12-month price target?+
The 2 analysts with a live target average $6.00 for Kezar Life Sciences Inc over the next 12 months, ranging from a $7.00 high to a $5.00 low.
Is KZR stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 3 analyst ratings, 0 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for KZR?+
The Street-high target is $7.00 (Jefferies), and the Street-low is $5.00 (Wells Fargo). The average of all 2 active targets is $6.00.
How many Wall Street analysts cover KZR?+
3 analysts have an active rating on Kezar Life Sciences Inc, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering KZR?+
Among analysts who currently cover KZR, Raghuram Selvaraju of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #249). Their current call is Hold.
Have analysts been upgrading or downgrading KZR lately?+
As of Jul, 0 of 3 firms rate KZR a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their KZR calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
